New AVCAL Chair
15 February 2012
The Australian Private Equity & Venture Capital Association (AVCAL) has appointed Mr David Brown as the new Chair of the governing Council.
Mr Brown, who has been a Member of the Council for the past three and a half years, formally takes over the role at the next Council meeting tomorrow.
AVCAL CEO Dr Katherine Woodthorpe said Mr Brown’s long background in funds management and private equity as an investor reflects the diverse range of stakeholders across the industry.
“David’s investor background reinforces the fact that AVCAL comprises the full private equity and venture capital community, from investors to private equity practitioners and service providers. David is passionate about private equity as an asset class that delivers strong and reliable returns and is already contributing his strategic insights and knowledge to advocate on behalf of the industry.”
Mr Brown replaces industry stalwart Andrew Rothery who has held the chairmanship for the past three years.
“I'd like to express my deep gratitude and appreciation to the out-going Chair Andrew Rothery, who has made a huge contribution to the private equity industry over his time as Chair. Andrew’s skills and commitment have been invaluable in guiding AVCAL over that period,” Dr Woodthorpe said.
Mr Brown said: “The Private Equity and Venture industry is an important and valuable driver of growth and innovation in the Australian economy. Our companies are at the forefront of productivity growth and the benefits flow directly back to Australians in the form of investment returns via their Super funds. Private Equity has emerged from the GFC as one of the best performing asset classes over the last few years, delivering returns well above inflation and the stock market.”
“It has always been a delight to work with such an enthusiastic Council and I look forward to engaging with and listening to a wide spectrum of our stakeholders.”
Stuart Snell, Communications Manager, Ph +61 (0)2 8242 7001, (0)416 650 906, email@example.com
Author: Yasser El-Ansary, Chief Executive, AVCAL
Author: Dr Noel Chambers, CEO, National Foundation for Medical Research and Innovation